Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review

Abstract

This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology was performed from January 2020 until July 2021. The MEDLINE, Lilacs, and Scielo databases were searched to identify studies related to COPD and its comorbidities. Observational studies on the prevalence of comorbidities in COPD patients and costs with health estimates, reduced quality of life, and mortality were included. Studies that were restricted to one or more COPD pain assessments and only specific comorbidities such as osteoporosis, bronchitis, and asthma were excluded. The initial search identified 1,409 studies and after applying the inclusion and exclusion criteria, 20 studies were finally selected for analysis (comprising data from 447,459 COPD subjects). The most frequent COPD comorbidities were: hypertension (range, 17%–64.7%), coronary artery disease (19.9%–47.8%), diabetes (10.2%–45%), osteoarthritis (18%–43.8%), psychiatric conditions (12.1%–33%), and asthma (14.7%–32.5%). Several comorbidities had an impact on the frequency and severity of COPD exacerbations, quality of life, and mortality risk, in particular malignancies, coronary artery disease, chronic heart failure, and cardiac arrhythmias. Comorbidities, especially cardiovascular diseases and diabetes, are frequent in COPD patients, and some of them are associated with higher mortality.

Evaluation of the Effect of COVID-19 Vaccination on Exacerbations of Chronic Obstructive Pulmonary Disease: A Single-Center Study

“…The additional comorbidities of the patients were observed to be present in the majority of the study group, which, combined with the advanced age of the patients, supported the initial assumption of the group being considered fragile compared to the general population. In accordance with the literature, these factors effectively played a role in high COPD exacerbations in our study [17,18]. There are many studies in the literature stating that there is a negative correlation between forced expiratory volume in one second (FEV1) levels and hospital stay [19,20].…”

Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019

“…Unlike the young population, elderly people have many comorbidities, usually take many prescription drugs, and their metabolism is slow. 39 40 …”

Impact of Previous Occupational Exposure on Outcomes of Chronic Obstructive Pulmonary Disease

“…However, these results are consistent with findings of several previously reported studies analyzing the quality of life in COPD patients. According to the previous studies, poor quality of life showed an association with comorbidities, uncontrolled respiratory symptoms such as sputum, or pulmonary hyperinflation (represented by residual volume/total lung capacity), while no significant association was observed with regard to smoking history or airflow limitation [ 39 , 40 , 41 ].…”